toxin conjugated monoclonal VEGF-R2 targeted antibodies (AbTech)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nametoxin conjugated monoclonal VEGF-R2 targeted antibodies (AbTech)
Drug Alias NameAbTEC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionVascular endothelial growth factor receptor 2 agonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbTech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbTech
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A